Oklahoma OTC Manufacturer Cited for Multiple Violations

Drug Industry Daily
A A
The FDA hit OTC drug manufacturer Tomco-Harwel Industries with an extensive Form 483 for numerous violations at its Tulsa, Oklahoma facility.

To View This Article:

Login

Subscribe To Drug Industry Daily